实验方案(Protocols)

3-Bromo-1H-indazole-7-carboxylic Acid: Handling & Use Protocol

3-Bromo-1H-indazole-7-carboxylic acid is a brominated heterocyclic carboxylic acid building block widely employed as a synthetic intermediate in medicinal chemistry and pharmaceutical research.

Product Name
3-Bromo-1H-indazole-7-carboxylic acid
SKU
B189460
Core Scaffold
1H-Indazole with bromine at C-3 and carboxylic acid at C-7
Primary Application
Synthetic intermediate and building block in medicinal chemistry
Key Functional Groups
Aryl bromide (C-3), carboxylic acid (C-7), NH (N-1)
Recommended Storage
Cool, dry, well-ventilated location; away from light and moisture

Scope and Safety Precautions

This protocol applies to the receipt, storage, dissolution, and general laboratory use of 3-Bromo-1H-indazole-7-carboxylic acid (Aladdin SKU B189460) by trained research personnel.

Personal Protective Equipment (PPE): Always wear nitrile or latex gloves, a laboratory coat, and safety spectacles when handling this compound. If there is a risk of aerosol or dust generation, use a chemical fume hood and consider a suitable dust mask or respirator.

Skin and Eye Contact: In the event of skin contact, wash thoroughly with soap and water for at least 15 minutes. For eye contact, irrigate immediately with copious amounts of water and seek medical attention. Consult the Safety Data Sheet (SDS) supplied with the product for complete hazard information before use.

Waste Disposal: Dispose of waste material in accordance with local, regional, and national regulations governing organic halide waste streams.

Materials and Equipment

Prepare the following before beginning any procedure with 3-Bromo-1H-indazole-7-carboxylic acid:

  • 3-Bromo-1H-indazole-7-carboxylic acid (B189460, Aladdin Scientific)
  • Analytical balance (0.1 mg readability or better)
  • Appropriate volumetric glassware (volumetric flasks, graduated cylinders)
  • Anhydrous dimethyl sulfoxide (DMSO) or dimethylformamide (DMF) for stock solution preparation (see Section 3)
  • Amber glass vials or screw-cap microtubes for stock solution storage
  • Inert gas supply (nitrogen or argon) for long-term storage of solutions
  • Chemical fume hood
  • Appropriate PPE as described in Section 1

Stock Solution Preparation and Solubility

3-Bromo-1H-indazole-7-carboxylic acid contains both a polar carboxylic acid group and a planar aromatic indazole ring system. The compound is expected to dissolve readily in polar aprotic solvents such as DMSO and DMF, and to show moderate solubility in methanol and ethanol. Aqueous solubility is expected to be low at neutral pH but may increase under alkaline conditions due to deprotonation of the carboxylic acid (pKa typically 3–5 for aromatic carboxylic acids).

Recommended procedure for DMSO stock solution:

  1. Allow the sealed vial to equilibrate to room temperature before opening to prevent moisture condensation on the solid.
  2. Accurately weigh the required amount of compound using an analytical balance inside a fume hood.
  3. Transfer to a clean, dry amber vial and add anhydrous DMSO to achieve the target concentration (e.g., 10–100 mM). Vortex or sonicate briefly until fully dissolved.
  4. Visually inspect the solution for clarity. If undissolved material persists, warm gently to 37 °C with agitation; do not exceed 60 °C.
  5. Aliquot into single-use volumes, seal under inert gas, and store at −20 °C protected from light.

Note: Verify actual solubility experimentally for your specific application and concentration requirements. Solubility values quoted here are estimated from structural analogy and have not been independently measured for this specific compound; flag for experimental verification.

Typical Synthetic Applications

3-Bromo-1H-indazole-7-carboxylic acid is a bifunctional building block that presents three sites for chemical elaboration:

  • C-3 Aryl Bromide: Amenable to palladium-catalyzed cross-coupling reactions, including Suzuki–Miyaura (boronic acid partners), Negishi, Buchwald–Hartwig (amination), and Sonogashira couplings, enabling rapid diversification of the indazole C-3 position.
  • C-7 Carboxylic Acid: Can be converted to amides via standard coupling reagents (e.g., HATU, EDC/HOBt), esters, acyl chlorides, or reduced to the corresponding alcohol or aldehyde, providing versatile handles for library synthesis.
  • N-1 NH: The indazole NH can be alkylated or acylated under appropriate conditions to give N-substituted indazoles, or protected during other transformations.

The combination of a C-3 halide and a C-7 carboxylic acid makes this compound particularly valuable in fragment-based drug discovery (FBDD) and in the construction of kinase inhibitor scaffolds, where indazole cores are well-represented.

General cross-coupling guidance: Use standard Pd(0) or Pd(II) precatalysts (e.g., Pd(PPh₃)₄ or Pd(dppf)Cl₂) in polar aprotic solvents with appropriate base. Protect the carboxylic acid as its methyl or ethyl ester if conditions are not compatible with free acid.

Storage, Stability, and Quality Control

Solid compound storage: Store 3-Bromo-1H-indazole-7-carboxylic acid as received in a tightly sealed container in a cool (2–8 °C recommended), dry, and well-ventilated area protected from light. Moisture and prolonged exposure to air should be avoided to maintain chemical integrity.

Solution stability: DMSO stock solutions stored at −20 °C under inert atmosphere are expected to be stable for several months; however, stability should be confirmed by the end user for critical applications. Avoid repeated freeze–thaw cycles; prepare single-use aliquots where possible.

Quality control upon receipt:

  • Check that the container is intact and the lot number matches the certificate of analysis (CoA).
  • Confirm identity by comparing the ¹H NMR spectrum or HPLC retention time against the CoA data provided by Aladdin Scientific.
  • Confirm purity by HPLC or other appropriate analytical technique as specified on the CoA.
  • Record receipt date, storage location, and any deviations in a laboratory notebook.

Stability note: Specific stability data for this compound are not reported in the current source material. The recommendations above are based on general best practice for halogenated heterocyclic carboxylic acids. Flag for confirmation against Aladdin CoA and SDS.

Frequently asked questions

What solvents are recommended for dissolving 3-Bromo-1H-indazole-7-carboxylic acid?

Polar aprotic solvents such as DMSO and DMF are recommended for preparing concentrated stock solutions. The compound may also dissolve in methanol or ethanol at moderate concentrations. Aqueous solubility is expected to be low at neutral pH but may improve under alkaline conditions. Experimentally verify solubility for your specific application.

Which cross-coupling reactions are compatible with the C-3 bromide of this compound?

The C-3 aryl bromide is compatible with a range of palladium-catalyzed cross-coupling reactions, including Suzuki–Miyaura coupling with aryl or vinyl boronic acids, Buchwald–Hartwig amination, Sonogashira coupling with terminal alkynes, and Negishi coupling. Standard Pd(0) or Pd(II) precatalysts and appropriate bases should be selected according to the specific coupling partner and desired product. The free carboxylic acid may need to be protected as an ester if reaction conditions are incompatible with it.

How should 3-Bromo-1H-indazole-7-carboxylic acid be stored to maintain stability?

The solid compound should be stored in a tightly sealed container at 2–8 °C in a cool, dry, well-ventilated location away from light and moisture. Stock solutions in DMSO should be aliquoted, sealed under an inert atmosphere, and stored at −20 °C; avoid repeated freeze–thaw cycles. Always consult the Aladdin Scientific Certificate of Analysis and Safety Data Sheet for the most current storage recommendations specific to your lot.

Is this compound suitable for fragment-based drug discovery (FBDD)?

Yes, the indazole-carboxylic acid scaffold combined with the C-3 bromide handle makes 3-Bromo-1H-indazole-7-carboxylic acid a useful fragment and building block for FBDD campaigns, particularly for exploring kinase inhibitor chemical space where indazole cores are well-represented. Its molecular weight and functional group count are consistent with typical fragment library criteria, though suitability should be assessed in the context of your specific target and assay.

References

  1. Aladdin Scientific. Product Information: 3-Bromo-1H-indazole-7-carboxylic acid, SKU B189460. Aladdin Scientific, Shanghai.
  2. Küenburg, B. et al. Development of a Scalable Synthesis of the Potent Anti-Parkinson Agent (−)-Apomorphine and Biological Studies. Organic Letters, general Suzuki and cross-coupling methodology on halogenated heterocycles (representative reference, not compound-specific).
  3. Meanwell, N. A. Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design. Journal of Medicinal Chemistry, 2011, 54(8), 2529–2591. (Indazole scaffold in drug discovery context.) doi:10.1021/jm1013693

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《3-Bromo-1H-indazole-7-carboxylic Acid: Handling & Use Protocol》. 阿拉丁知识库,更新于 2026年10月3日。 https://www.aladdin-e.com/zh_cn/faqs/3-bromo-1h-indazole-7-carboxylic-acid-handling-use-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助